KOURTNEY ATWOOD: Open Payments
NPI 1962928978 · HELPER, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 30 payments from 11 companies in 2025. Trend: 2023 $301 · 2024 $492 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 11 | $148 |
| ABBVIE INC. | 3 | $73 |
| Neurocrine BioSciences, Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Janssen Pharmaceuticals, Inc | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Braeburn Inc. | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
Products named: ARISTADA, VRAYLAR, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, COBENFY, CAPLYTA, BRIXADI.
Industry payments across UT — which companies pay providers there.
